[Federal Register: February 7, 2003 (Volume 68, Number 26)]
[Notices]
[Page 6471-6475]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr07fe03-75]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Program Announcement 03024]
Grants for Violence-Related Injury Prevention Research: Intimate
Partner Violence and Sexual Violence; Notice of Availability of Funds
Application Deadline: April 8, 2003.
A. Authority and Catalog of Federal Domestic Assistance Number
This program is authorized under section 301(a) [42 U.S.C. 241(a)]
of the Public Health Service Act and section 391(a) [42 U.S.C. 280b(a)]
of the Public Health Service Act, as amended. The catalog of Federal
Domestic Assistance number is 93.136.
B. Purpose
The Centers for Disease Control and Prevention (CDC) announces the
availability of fiscal year (FY) 2003 funds for grants for Intimate
Partner Violence and Sexual Violence Injury Prevention Research. This
program addresses the ``Healthy People 2010'' focus area of Injury and
Violence Prevention.
The purposes of the program are to:
1. Solicit research applications that address the priorities
reflected under the ``Programmatic Requirements.''
2. Build the scientific base for the prevention and control of
injuries, disabilities, and deaths.
3. Encourage professionals from a wide spectrum of disciplines of
engineering, epidemiology, medicine, biostatistics, public health, law
and criminal justice, and behavioral, and social sciences to perform
research in order to prevent and control injuries more effectively.
4. Encourage investigators to propose research that involves
intervention development and testing as well as research on methods, to
encourage individuals, organizations, or communities to adopt and
maintain effective intervention strategies.
Measurable outcomes of the program will be in alignment with the
following performance goal for the National Center for Injury
Prevention and Control (NCIPC): Develop new or improved approaches for
preventing and controlling death and disability due to injuries.
C. Eligible Applicants
Applications may be submitted by public and private nonprofit and
for profit organizations and by governments and their agencies; that
is, universities, colleges, technical schools, research institutions,
hospitals, other public and private nonprofit and for profit
organizations, community-based organizations, faith-based
organizations, state and local governments or their bona fide agents,
including the District of Columbia, the Commonwealth of Puerto Rico,
the Virgin Islands, the Commonwealth of the Northern Mariana Islands,
American Samoa, Guam, the Federated States of Micronesia, the Republic
of the Marshall Islands, and the Republic of Palau, Federally
recognized Indian tribal governments, Indian tribes, or Indian tribal
organizations, and small, minority, and/or women-owned businesses.
Note: Title 2 of the United States Code section 1611 states that
an organization described in section 501(c)(4) of the Internal
Revenue Code that engages in lobbying activities is not eligible to
receive Federal funds constituting an award, grant or loan.
Applications that are incomplete or non-responsive to the below
requirements will be returned to the applicant without further
consideration. The following are applicant requirements:
1. A principal investigator who has conducted research, published
the findings in peer-reviewed journals, and has specific authority and
responsibility to carry out the proposed project.
2. Demonstrated experience on the applicant's project team in
conducting, evaluating, and publishing injury control research in peer-
reviewed journals.
3. Effective and well-defined working relationships within the
performing organization and with outside entities, which will ensure
implementation of the proposed activities.
4. The ability to carry out injury control research projects as
defined under Attachment 2 (1.a-c). The attachment is posted with this
announcement on the CDC Web site: http://frwebgate.access.gpo.gov/cgi-bin/leaving.cgi?from=leavingFR.html&log=linklog&to=http://www.cdc.gov/ncipc/ncipchm.htm.
5. The overall match between the applicant's proposed theme and
research objectives and the program priorities as described under the
heading, ``Program Requirements.''
D. Funding
Availability of Funds
Approximately $1,200,000 is expected to be available in FY 2003 to
fund approximately 4-6 awards for intimate partner violence and sexual
violence research grants. It is expected that the awards will begin on
or about September 1, 2003, and will be made for
[[Page 6472]]
a 12-month budget period within a three-year project period. The
maximum funding level will not exceed $300,000 (including both direct
and indirect costs) per year and $900,000 for the three-year project
period. The specific program priorities for these funding opportunities
are outlined with examples in this announcement under the section,
``Programmatic Requirements.''
Applications that exceed the funding caps noted above will be
excluded from the competition and returned to the applicant. The
availability of Federal funding may vary and is subject to change.
Consideration will also be given to current grantees that submit a
competitive supplement requesting one year of funding to enhance or
expand existing projects, or to conduct one-year pilot studies. These
awards will not exceed $150,000, including both direct and indirect
costs. Supplemental awards will be made for the budget period to
coincide with the actual budget period of the grant and are based on
the availability of funds.
Continuation awards within an approved project period will be made
based on satisfactory progress demonstrated by investigators at work-
in-progress monitoring workshops (travel expenses for this annual one
day meeting should be included in the applicant's proposed budget), and
the achievement of work plan milestones reflected in the continuation
application.
Use of Funds
Grant funds will not be made available to support the provision of
direct care. Eligible applicants may enter into contracts, including
consortia agreements, as necessary to meet the requirements of the
program and strengthen the overall application.
Recipient Financial Participation
Matching funds are not required for this program.
E. Program Requirements
NCIPC is soliciting investigator-initiated research that will help
expand and advance our understanding of violence, its causes, and
prevention strategies.
The following research themes are the focus of this investigator-
initiated solicitation:
1. Evaluate strategies for disseminating and implementing evidence-
based interventions or policies for the prevention of intimate partner
violence and sexual violence.
2. Evaluate the efficacy, effectiveness, and cost effectiveness of
interventions, programs, and policies to prevent intimate partner
violence and sexual violence.
3. Identify shared and unique risk and protective factors for the
perpetration of intimate partner violence and sexual violence and
examine the relationships among these forms of violence and others such
as child maltreatment, youth violence, or suicidal behavior.
Additional information may be found for all attachments as posted
with this announcement on the CDC Web site: http://frwebgate.access.gpo.gov/cgi-bin/leaving.cgi?from=leavingFR.html&log=linklog&to=http://www.cdc.gov.
F. Content
Letter of Intent (LOI)
A LOI is optional for this program. The narrative should be no more
than two single-spaced pages, printed on one side, with one-inch
margins, and unreduced 12-point font. The letter should identify the
announcement number, the name of the principal investigator, and
briefly describe the scope and intent of the proposed research work.
The letter of intent does not influence review or funding decisions,
but the number of letters received will enable CDC to plan the review
more effectively and efficiently.
Applications
The Program Announcement title and number must appear in the
application. Use the information in the Program Requirements, Other
Requirements, and Evaluation Criteria sections to develop the
application content. Your application will be evaluated on the criteria
listed, so it is important to follow them in laying out your program
plan. The narrative should be no more than 25 single-spaced pages,
printed on one side, with one-inch margins, and unreduced 12-point
font.
Applications should follow the PHS-398 (Rev. 5/2001) application
and Errata sheet (See Attachment 4 of this announcement). The narrative
should include the following information:
1. The project's focus that justifies the research needs and
describes the scientific basis for the research, the expected outcome,
and the relevance of the findings to reduce injury morbidity,
mortality, disability, and economic losses. This focus should be based
on recommendations in ``Healthy People 2010'' and the ``CDC Injury
Research Agenda'' and should seek creative approaches that will
contribute to a national program for injury control.
2. Specific, measurable, and time-framed objectives.
3. A detailed plan describing the methods by which the objectives
will be achieved, including their sequence. A comprehensive evaluation
plan is an essential component of the application.
4. A description of the principal investigator's role and
responsibilities.
5. A description of all the project staff regardless of their
funding source. It should include their title, qualifications,
experience, percentage of time each will devote to the project, as well
as that portion of their salary to be paid by the grant.
6. A description of those activities related to, but not supported
by the grant.
7. A description of the involvement of other entities that will
relate to the proposed project, if applicable. It should include
commitments of support and a clear statement of their roles.
8. A detailed first year's budget for the grant with future annual
projections, if relevant.
9. An explanation of how the research findings will contribute to
the national effort to reduce the morbidity, mortality and disability
caused by violence-related injuries within three to five years from
project start-up.
An applicant organization has the option of having specific salary
and fringe benefit amounts for individuals omitted from the copies of
the application, which are made available to outside reviewing groups.
To exercise this option: on the original and two copies of the
application, the applicant must use asterisks to indicate those
individuals for whom salaries and fringe benefits are not shown;
however, the subtotals must still be shown. In addition, the applicant
must submit an additional copy of page four of Form PHS-398, completed
in full, with the asterisks replaced by the salaries and fringe
benefits. This budget page will be reserved for internal staff use
only.
G. Submission and Deadline
Letter of Intent (LOI) Submission
On or before March 10, 2003, submit the LOI to the Grants
Management Specialist identified in the ``Where to Obtain Additional
Information'' section of this announcement.
Application Forms
Submit the original and two copies of PHS 398 (OMB Number 0925-
0001) (adhere to the instructions on the Errata Instruction Sheet for
PHS 398). Forms are available at the following Internet address: http://frwebgate.access.gpo.gov/cgi-bin/leaving.cgi?from=leavingFR.html&log=linklog&to=http://www.cdc.gov/od/pgo/forminfo.htm
.
If you do not have access to the Internet, or if you have
difficulty accessing the forms on-line, you may contact the CDC
Procurement and
[[Page 6473]]
Grants Office Technical Information Management Section (PGO-TIM) at:
770-488-2700. Application forms can be mailed to you.
Submission Date, Time, and Address
The application must be received by 4 p.m. Eastern Time April 8,
2003. Submit the application to: Technical Information Management-
PA03024, CDC Procurement and Grants Office, 2920 Brandywine Road,
Atlanta, GA 30341-4146.
Applications may not be submitted electronically.
CDC Acknowledgment of Application Receipt
A postcard will be mailed by PGO-TIM, notifying you that CDC has
received your application.
Deadline
Letters of intent and applications shall be considered as meeting
the deadline if they are received before 4 p.m. Eastern Time on the
deadline date. Applicants sending applications by the United States
Postal Service or commercial delivery services must ensure that the
carrier will be able to guarantee delivery of the application by the
closing date and time. If an application is received after closing due
to (1) carrier error, when the carrier accepted the package with a
guarantee for delivery by the closing date and time, or (2) significant
weather delays or natural disasters, CDC will upon receipt of proper
documentation, consider the application as having been received by the
deadline.
Applications, which do not meet the above criteria, will not be
eligible for competition and will be discarded. Applicants will be
notified of their failure to meet the submission requirements.
H. Evaluation Criteria
Upon receipt, applications will be reviewed by CDC staff for
completeness and responsiveness as outlined under the ``Eligible
Applicants'' Section (Items one through five). Incomplete applications
and applications that are not responsive will be returned to the
applicant without further consideration. It is especially important
that the applicant's abstract reflects the project's focus, because the
abstract will be used to help determine the responsiveness of the
application.
Applications which are complete and responsive may be subjected to
a preliminary evaluation (streamline review) by a peer review
committee, the Injury Research Grant Review Committee (IRGRC), to
determine if the application is of sufficient technical and scientific
merit to warrant further review by the IRGRC; CDC will withdraw from
further consideration applications judged to be noncompetitive and
promptly notify the principal investigator/program director and the
official signing for the applicant organization. Those applications
judged to be competitive will be further evaluated by a dual review
process.
Competing supplemental grant awards may be made, when funds are
available, to support research work or activities not previously
approved by the IRGRC. Applications should be clearly labeled to denote
their status as requesting supplemental funding support. These
applications will be reviewed by the IRGRC and the secondary review
group.
All awards will be determined by the Director of the NCIPC based on
priority scores assigned to applications by the primary review
committee IRGRC, recommendations by the secondary review committee of
the Science and Program Review Subcommittee of the Advisory Committee
for Injury Prevention and Control (ACIPC), consultation with NCIPC
senior staff, and the availability of funds.
1. The primary review will be a peer review conducted by the IRGRC.
All applications will be reviewed for scientific merit using current
National Institutes of Health (NIH) criteria (a scoring system of 100-
500 points) to evaluate the methods and scientific quality of the
application. All categories are of equal importance, however, the
application does not need to be strong in all categories to be judged
likely to have a major scientific impact. Factors to be considered will
include:
a. Significance. Does this study address an important problem? If
the aims of the application are achieved, how will scientific knowledge
be advanced? What will be the effect of these studies on the concepts
or methods that drive this field?
b. Approach. Are the conceptual framework, design, methods, and
analyses adequately developed, well-integrated, and appropriate to the
aims of the project? Does the applicant acknowledge potential problem
areas and consider alternative tactics? Does the project include plans
to measure progress toward achieving the stated objectives? Is there an
appropriate work plan included?
c. Innovation. Does the project employ novel concepts, approaches
or methods? Are the aims original and innovative? Does the project
challenge or advance existing paradigms, or develop new methodologies
or technologies?
d. Investigator. Is the principal investigator appropriately
trained and well suited to carry out this work? Is the proposed work
appropriate to the experience level of the principal investigator and
other significant investigator participants? Is there a prior history
of conducting violence-related research?
e. Environment. Does the scientific environment in which the work
will be done contribute to the probability of success? Does the
proposed research take advantage of unique features of the scientific
environment or employ useful collaborative arrangements? Is there
evidence of institutional support? Is there an appropriate degree of
commitment and cooperation of other interested parties as evidenced by
letters detailing the nature and extent of the involvement?
f. Ethical Issues. What provisions have been made for the
protection of human subjects and the safety of the research
environments? How does the applicant plan to handle issues of
confidentiality and compliance with mandated reporting requirements,
e.g., suspected child abuse? Does the application adequately address
the requirements of 45 CFR Part 46 for the protection of human
subjects? (An application can be disapproved if the research risks are
sufficiently serious and protection against risks is so inadequate as
to make the entire application unacceptable.) The degree to which the
applicant has met the CDC Policy requirements regarding the inclusion
of women, ethnic, and racial groups in the proposed research (See
Attachment 1, AR-2). This includes:
(1) The proposed plan for the inclusion of both sexes and racial
and ethnic minority populations for appropriate representation.
(2) The proposed justification when representation is limited or
absent.
(3) A statement as to whether the design of the study is adequate
to measure differences when warranted.
(4) A statement as to whether the plans for recruitment and
outreach for study participants include the process of establishing
partnerships with community(ies) and recognition of mutual benefits.
g. Study Samples. Are the samples sufficiently rigorously defined
to permit complete independent replication at another site? Have the
referral sources been described, including the definitions and
criteria? What plans have been made to include women and minorities and
their subgroups as appropriate for the scientific goals of the
[[Page 6474]]
research? How will the applicant deal with recruitment and retention of
subjects?
h. Dissemination. What plans have been articulated for
disseminating findings?
i. Measures of Effectiveness. The Peer Review Panel shall assure
that measures set forth in the application are in accordance with CDC's
performance plans (See attachment). How adequately has the applicant
addressed these measures?
The IRGRC will also examine the appropriateness of the proposed
project budget and duration in relation to the proposed research and
the availability of data required for the project.
2. The secondary review will be conducted by the Science and
Program Review Subcommittee (SPRS) of the ACIPC. The ACIPC Federal
agency experts will be invited to attend the secondary review, will
receive modified briefing books (i.e., abstracts, strengths and
weaknesses from summary statements, and project officer's briefing
materials). The ACIPC Federal agency experts will be encouraged to
participate in deliberations when applications address overlapping
areas of research interest so that unwarranted duplication in
federally-funded research can be avoided and special subject area
expertise can be shared. The NCIPC Division Associate Directors for
Science (ADS) or their designees will attend the secondary review in a
similar capacity as the ACIPC Federal agency experts to assure that
research priorities of the announcement are understood and to provide
background regarding current research activities. Only SPRS members
will vote on funding recommendations, and their recommendations will be
carried to the entire ACIPC for voting by the ACIPC members in closed
session. If any further review is needed by the ACIPC, regarding the
recommendations of the SPRS, the factors considered will be the same as
those considered by the SPRS.
The committee's responsibility is to develop funding
recommendations for the NCIPC Director based on the results of the
primary review, the relevance and balance of proposed research relative
to the NCIPC programs and priorities, and to assure that unwarranted
duplication of federally-funded research does not occur. The secondary
review committee has the latitude to recommend to the NCIPC Director,
to reach over better-ranked proposals in order to assure maximal impact
and balance of proposed research. The factors to be considered will
include:
a. The results of the primary review including the application's
priority score as the primary factor in the selection process.
b. The relevance and balance of proposed research relative to the
NCIPC programs and priorities.
c. The significance of the proposed activities in relation to the
priorities and objectives stated in ``Healthy People 2010,'' the
Institute of Medicine report, ``Reducing the Burden of Injury,'' and
the ``CDC Injury Research Agenda.''
d. Budgetary considerations.
3. Continued Funding
Continuation awards made after FY 2003, but within the project
period, will be made on the basis of the availability of funds and the
following criteria:
a. The accomplishments reflected in the progress report of the
continuation application indicate that the applicant is meeting
previously stated objectives or milestones contained in the project's
annual work plan and satisfactory progress demonstrated through
presentations at work-in-progress monitoring workshops.
b. The objectives for the new budget period are realistic,
specific, and measurable.
c. The methods described will clearly lead to achievement of these
objectives.
d. The evaluation plan will allow management to monitor whether the
methods are effective.
e. The budget request is clearly explained, adequately justified,
reasonable and consistent with the intended use of grant funds.
I. Other Requirements
Technical Reporting Requirements
Provide CDC with an original plus two copies of:
1. Annual progress report. The progress report will include a data
requirement that demonstrates measures of effectiveness.
2. A financial status report, no more than 90 days after the end of
the budget period.
3. Final financial report and performance report, no more than 90
days after the end of the project period.
4. At the completion of the project, the grant recipient will
submit a brief (2,500 to 4,000 words written in non-scientific
[laymen's] terms) summary highlighting the findings and their
implications for injury prevention programs, policies, environmental
changes, etc. The grant recipient will also include a description of
the dissemination plan for research findings. This plan will include
publications in peer-reviewed journals and ways in which research
findings will be made available to stakeholders outside of academia,
(e.g., state injury prevention program staff, community groups, public
health injury prevention practitioners, and others). CDC will place the
summary report and each grant recipient's final report with the
National Technical Information Service (NTIS) to further the agency's
efforts to make the information more available and accessible to the
public.
Send all reports to the Grants Management Specialist identified in
the ``Where to Obtain Additional Information'' section of this
announcement.
Additional Requirements
The following additional requirements are applicable to this
program. For a complete description of each see Attachment 1 of this
announcement as posted on the CDC web site.
AR-1 Human Subjects Certification
AR-2 Requirements for inclusion of Women and Racial and Ethnic
Minorities in Research
AR-3 Animal Subjects Requirement
AR-9 Paperwork Reduction Requirements
AR-10 Smoke-Free Workplace Requirement
AR-11 Healthy People 2010
AR-12 Lobbying Restrictions
AR-13 Prohibition on Use of CDC funds for Certain Gun Control
Activities
AR-21 Small, Minority, and Women-owned Business
AR-22 Research Integrity
Executive Order 12372 does not apply to this program.
J. Where To Obtain Additional Information
This and other CDC announcements, the necessary applications, and
associated forms can be found on the CDC Web site, Internet address:
http://frwebgate.access.gpo.gov/cgi-bin/leaving.cgi?from=leavingFR.html&log=linklog&to=http://www.cdc.gov. Click on ``Funding,'' then ``Grants and Cooperative
Agreements.''
For business management assistance, contact: Angie Nation, Grants
Management Specialist, Procurement and Grants Office, Centers for
Disease Control and Prevention, 2920 Brandywine Road, Room 3000,
Atlanta, GA 30341-4146, Telephone: (770) 488-2719, E-mail address:
aen4@cdc.gov.
For program technical assistance, contact: Tom Voglesonger, Program
Manager, Office of the Director, National Center for Injury Prevention
and Control, Centers for Disease Control and Prevention (CDC), 4770
Buford Highway, NE, Mail Stop K-02, Atlanta, GA 30341-3724, Telephone:
(770) 488-4823, Internet address: TVoglesonger@cdc.gov.
[[Page 6475]]
Dated: February 1, 2003.
Sandra R. Manning,
Director, Procurement and Grants Office, Centers for Disease Control
and Prevention.
[FR Doc. 03-3034 Filed 2-6-03; 8:45 am]
BILLING CODE 4163-18-P